| Literature DB >> 29988730 |
H Waterman1, S Bull2, M Shaw3,4, C Richardson3,4.
Abstract
BACKGROUND: Globally, glaucoma is the leading cause of irreversible blindness. However, many patients with glaucoma do not understand their disease which reportedly impacts on their ability to manage their condition successfully. The aim of this feasibility study was to undertake research to inform a future randomised controlled trial of the effectiveness of group-based education for patients to improve adherence to glaucoma eyedrops.Entities:
Keywords: Adherence; Clinical guidelines; Clinical standards; Glaucoma; Group-based education; Nurse; Patient compliance
Year: 2018 PMID: 29988730 PMCID: PMC6029365 DOI: 10.1186/s40814-018-0313-5
Source DB: PubMed Journal: Pilot Feasibility Stud ISSN: 2055-5784
Fig. 1Patient recruitment flow for phase 1 of the study
Demographic information on participants in phase 1 of the research
| Demographic category | Response | 112 patients |
|---|---|---|
| Mean age | – | 71 years |
| Time since diagnosis | – | 7.2 years |
| Gender | Male | 55% (61) |
| Female | 45% (51) | |
| Ethnicity | White | 95% (106) |
| Black | 2% (2) | |
| Asian | 4% (4) | |
| Diagnosis | COAG | 60% (67) |
| OHT | 21% (24) | |
| Suspected COAG | 6% (7) | |
| NTG | 9% (10) | |
| Not stated | 4% (4) | |
| Field loss | Yes | 55% (61) |
| No | 38% (43) | |
| Don’t know | 4% (4) | |
| Not stated | 3% (3) | |
| Low test reliability | < 1% (1) | |
| Employment status | Retired | 75% (84) |
| Employed full time | 13% (14) | |
| Unemployed | 3% (3) | |
| Employed part time | 2% (2) | |
| Unable to work NOT due to an eye condition | 3% (3) | |
| Not stated | 4% (6) |
Key: COAG chronic open-angle glaucoma, OHT ocular hypertension, NTG normal tension glaucoma
Information provided to patients during phase 1 and phase 3
| Category from the VIM tool | Phase 1 | Phase 3 |
|---|---|---|
| 112 patients | 16 patients | |
| Management—investigations, e.g. fields test | 88% (99) | 100% (16) |
| Self-management—importance of taking eyedrops | 83% (93) | 100% (16) |
| Management—regular monitoring | 63% (70) | 81% (13) |
| Management—appointment issues | 63% (70) | 94% (15) |
| Treatment—options for eyedrops | 60% (67) | 100% (16) |
| Risk—family | 55% (62) | 100% (16) |
| Diagnosis | 54% (60) | 100% (16) |
| Treatment—side effects | 43% (48) | 100% (16) |
| Prognosis—loss of sight | 24% (27) | 100% (16) |
| Driving | 16% (18) | 94% (15) |
| Support—help with eyedrops | 13% (15) | 100% (16) |
| Prognosis—symptomless | 11% (12) | 100% (16) |
| Prognosis—sight can’t be recovered | 10% (11) | 100% (16) |
| Support—support groups | 10% (11) | 94% (15) |
| Prognosis—when treated most don’t go blind | 3% (3) | 100% (16) |
| Registration of loss of sight | 2% (2) | 6% (1) |
NB. Phase 3, registration of loss of sight, one patient was given information in response to an individual question which was not widely discussed with the whole group
VIM Provision of Vision Information Measurement tool
Fig. 2Patient recruitment flow for phase 3 of the research
Provision of Vision Information Measurement tool (VIM)
| Definition | Yes | No | N/A | Unable to answer |
|---|---|---|---|---|
| Diagnosis | ||||
| Prognosis | ||||
| Prognosis | ||||
| Prognosis | ||||
| Prognosis | ||||
| Management | ||||
| Management | ||||
| Management | ||||
| Risk factors | ||||
| Self-management | ||||
| Treatment | ||||
| Treatment | ||||
| Support | ||||
| Support | ||||
| Driver and Vehicle Licensing Agency (DVLA) regulations | ||||
| Letter of Vision Impairment (LVI), Referral of Vision Impaired Patient (RVI) and Certificate of Vision Impairment (CVI) registration | ||||
| Other | ||||
| Other | ||||
| Other | ||||
| Other | ||||
| Other |